GUILFORD, Conn.–(Business WIRE)–Could 09, 2022–Quantum-Si Included (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a daily life sciences business commercializing single molecule protein sequencing, now declared the appointment of Patrick Schneider, Ph.D., as President and Main Running Officer (COO). Schneider will thrive Michael McKenna, Ph.D., who will remain as Government Vice President, Products Progress and Functions.
“We have designed substantial development to launching the world’s 1st real subsequent technology protein sequencing procedure and I am thrilled to work with Patrick to elevate the chance of our near-time period and very long-phrase success,” explained Jonathan Rothberg, Ph.D., Interim Chief Government Officer, Founder and Executive Chairman of Quantum-Si. “Patrick brings extra than two many years of life science senior leadership knowledge and I am energized to be equipped to go the day-to-day management of this gifted crew to him as we execute our bold strategies to renovate the proteomics landscape.”
Schneider delivers about 25 yrs of knowledge as an attained lifestyle science leader and entrepreneur. Schneider joins Quantum-Si from MilliporeSigma, the place he most lately served as Senior Vice President of System, Small business Development and Innovation, and Chair of the Lifestyle Science Innovation Board. In the course of his 16-year tenure with MilliporeSigma and its predecessor entities, Schneider held roles of raising accountability and led method growth for the Investigation Options Small business Unit, executed in excess of 250 technological innovation obtain, co-improvement and distribution agreements, produced in- and out-licensing techniques, and oversaw a worldwide staff of more than 300 biologists, chemists and engineers. Earlier in his career, Schneider served as Vice President of R&D, Enterprise Growth and Scientific Affairs at Serologicals, Inc., wherever he designed and carried out the company’s M&A and partnership method. He also served as Chief Scientific Officer at Chemicon International, wherever he established the Beckman Institute for Biomedical Investigation and co-founded Genome Biosciences, Inc., and Integrated Cell Technologies, Inc.
“I’m honored to enable lead this impressive enterprise into the long term of following technology protein sequencing,” mentioned Dr. Schneider. “I am psyched about the Quantum-Si technological innovation – to carry the electrical power and scalability of semiconductor chip technology to this industry and aid solution inquiries in proteomics that could be also tricky or high-priced to answer utilizing historical techniques. Together with the rest of the management crew, I’m eager to start off constructing this ecosystem with our initially start this year.”
Schneider holds a B.S. in microbiology from Northern Arizona College and attained a Ph.D. in biology from the College of California, Irvine, in which he conducted virology analysis for neurotropic RNA viruses.
About Quantum-Si Incorporated
Quantum-Si is centered on revolutionizing the expanding discipline of proteomics. The Firm’s suite of technologies is driven by a very first-of-its-kind semiconductor chip designed to permit solitary molecule future-generation protein sequencing and digitize proteomic investigate in order to advance drug discovery and diagnostics over and above what has been attainable with DNA sequencing. Discover more at www.quantum-si.com.
Ahead Searching Statements
This push launch consists of “ahead-searching statements” in just the this means of the “secure harbor” provisions of the United States Non-public Securities Litigation Reform Act of 1995. The precise final results of the Enterprise may well vary from its expectations, estimates, and projections and, therefore, you must not rely on these forward-on the lookout statements as predictions of future events. Phrases these types of as “expect,” “estimate,” “job,” “price range,” “forecast,” “foresee,” “intend,” “plan,” “could,” “will,” “could,” “ought to,” “thinks,” “predicts,” “potential,” “proceed,” and equivalent expressions (or the detrimental versions of such phrases or expressions) are meant to detect these ahead-wanting statements. These forward-hunting statements involve, devoid of limitation, the Firm’s expectations with respect to future general performance and improvement and commercialization of products and services. These forward-looking statements involve significant challenges and uncertainties that could lead to the genuine effects to vary materially from those people talked over in the forward-on the lookout statements. Most of these components are exterior the Firm’s command and are hard to predict. Variables that may lead to this kind of distinctions involve, but are not minimal to: the influence of COVID-19 on the Firm’s company the lack of ability to manage the listing of the Firm’s Class A popular stock on The Nasdaq Stock Market the skill to realize the predicted advantages of the not long ago done business enterprise combination, which might be afflicted by, between other matters, opposition and the capability of the Organization to expand and deal with progress profitably and retain its important workers our ongoing leadership changeover alterations in relevant regulations or restrictions the capability of the Business to elevate financing in the foreseeable future the good results, charge and timing of the Firm’s merchandise progress and commercialization activities the prospective characteristics and rewards of the Firm’s products and expert services the Company’s capacity to receive and preserve regulatory acceptance for its goods, and any associated limitations and limits of any accredited merchandise the Company’s ability to establish, in-license or get further technology the Company’s capability to retain its existing lease, license, manufacture and offer agreements the Firm’s capacity to contend with other corporations currently internet marketing or engaged in the improvement or commercialization of products and solutions that the Firm is producing the sizing and advancement possible of the markets for the Firm’s future merchandise and expert services, and its potential to serve people marketplaces, both alone or in partnership with other people the pricing of the Company’s items and expert services subsequent anticipated commercial launch the Company’s estimates concerning potential costs, future income, funds demands and requirements for extra funding the Company’s economic performance and other threats and uncertainties described below “Risk Elements” in the Company’s Once-a-year Report for the fiscal 12 months ended December 31, 2021, and in the Firm’s other filings with the SEC. The Organization cautions that the foregoing listing of elements is not distinctive. The Enterprise cautions readers not to area undue reliance on any forward-looking statements, which communicate only as of the day made. The Organization does not undertake or acknowledge any obligation or enterprise to release publicly any updates or revisions to any forward-looking statements to mirror any adjust in its anticipations or any modify in functions, circumstances, or conditions on which any such statement is primarily based.